Loading…

Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine

The effect of exogenous testosterone on prostatic carcinogenicity of N-nitrosobis(2-oxopropyl)amine (BOP) in intact and castrated rats was examined in Wistar-derived MRC rats. Daily administration of BOP (either s.c. or i.g.) for 3 days, at a dose of 20 mg/kg b.w. at the heights of prostatic cell pr...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 1987-11, Vol.47 (21), p.5699-5706
Main Authors: POUR, P. M, STEPAN, K
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 5706
container_issue 21
container_start_page 5699
container_title Cancer research (Chicago, Ill.)
container_volume 47
creator POUR, P. M
STEPAN, K
description The effect of exogenous testosterone on prostatic carcinogenicity of N-nitrosobis(2-oxopropyl)amine (BOP) in intact and castrated rats was examined in Wistar-derived MRC rats. Daily administration of BOP (either s.c. or i.g.) for 3 days, at a dose of 20 mg/kg b.w. at the heights of prostatic cell proliferation induced by testosterone, led to development of a large number of prostatic tumors, the incidence of which, however, was dependent on the duration of testosterone administration. Testosterone given for life following BOP administration induced prostatic cancer in over 60% of rats, regardless of whether BOP was given orally or s.c., or whether the rats were orchiectomized or not, whereas tumor incidence was significantly lower in rats treated with testosterone for only a short period of time. One (3%) orchiectomized rat, which received testosterone only during BOP treatment, and four (15%) of rats treated with testosterone only for life also developed carcinomas. Histologically, a large number of BOP + testosterone-induced prostatic tumors were adenocarcinomas of various histological patterns and arose primarily from the dorsal lobe, whereas the great majority of squamous cell carcinomas were found in the ventral lobe. Simultaneously induced tumors were papillomas and carcinomas of the urinary bladder and urethra. Testosterone appeared to enhance the incidence of urinary bladder tumors, but not of the urethral tumors, whereas orchiectomy inhibited urethral carcinogenesis, and, to much lesser extent, urinary bladder tumor development. Rats treated weekly for 20 weeks with BOP (10 mg/kg/week i.g.) did not develop any prostatic tumors and all rats died of rectal cancer. Of rats treated similarly with BOP and with testosterone pellets for life following the last injection of BOP, 17% of rats developed prostatic cancer, all of the squamous cell type. Simultaneous testosterone and BOP treatment for 20 weeks followed by testosterone pellets for life resulted in a 39% tumor incidence (three adenocarcinomas, one anaplastic carcinoma, and five squamous cell carcinomas). The overall results suggest that testosterone plays an important role in the initiation of prostatic carcinogenesis, whereas the promotional phase is governed by the interaction of testosterone with other factors.
format article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_3664475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3664475</sourcerecordid><originalsourceid>FETCH-LOGICAL-h298t-6d78edfe1676eb597c9d625dbd03ba281bfb2b2b3531829b92fc0ade659427963</originalsourceid><addsrcrecordid>eNqFkM1KAzEUhYMotVYfQcjChS4GZjLJJLOU4k-h6EbX5eZnaGQmGZKU2hfz-cxocSuBGy7nu-dc7gmaV6wWBaeUnaJ5WZaiYJSTc3QR40duWVWyGZrVTUMpZ3P0tXJ6p5L1DvsOj8HHBMkqrCAo6_wAEYPTuPd7E_AuWAfhgFMAlbAzfuwhDhHLA1Z-kNYZnTUDaTAuTX7WpYmcHBTEPJYykWvEe5u2OJmYcqAJ3pkpe8xrZOSHfymcTXkdL228JYX_9BNw6O9gyDmX6KyDPpqr479A748Pb8vnYv36tFrer4staUUqGs2F0Z2pGt4YyVquWt0QpqUuawlEVLKTJL-a1ZUgrWxJp0rQpmEtJbxt6gW6_vUdd3IwejMGO-QLbI73y_rNUYeooO8COGXjH8YF5YJX_2JU0Dpj3_MHjKM</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>POUR, P. M ; STEPAN, K</creator><creatorcontrib>POUR, P. M ; STEPAN, K</creatorcontrib><description>The effect of exogenous testosterone on prostatic carcinogenicity of N-nitrosobis(2-oxopropyl)amine (BOP) in intact and castrated rats was examined in Wistar-derived MRC rats. Daily administration of BOP (either s.c. or i.g.) for 3 days, at a dose of 20 mg/kg b.w. at the heights of prostatic cell proliferation induced by testosterone, led to development of a large number of prostatic tumors, the incidence of which, however, was dependent on the duration of testosterone administration. Testosterone given for life following BOP administration induced prostatic cancer in over 60% of rats, regardless of whether BOP was given orally or s.c., or whether the rats were orchiectomized or not, whereas tumor incidence was significantly lower in rats treated with testosterone for only a short period of time. One (3%) orchiectomized rat, which received testosterone only during BOP treatment, and four (15%) of rats treated with testosterone only for life also developed carcinomas. Histologically, a large number of BOP + testosterone-induced prostatic tumors were adenocarcinomas of various histological patterns and arose primarily from the dorsal lobe, whereas the great majority of squamous cell carcinomas were found in the ventral lobe. Simultaneously induced tumors were papillomas and carcinomas of the urinary bladder and urethra. Testosterone appeared to enhance the incidence of urinary bladder tumors, but not of the urethral tumors, whereas orchiectomy inhibited urethral carcinogenesis, and, to much lesser extent, urinary bladder tumor development. Rats treated weekly for 20 weeks with BOP (10 mg/kg/week i.g.) did not develop any prostatic tumors and all rats died of rectal cancer. Of rats treated similarly with BOP and with testosterone pellets for life following the last injection of BOP, 17% of rats developed prostatic cancer, all of the squamous cell type. Simultaneous testosterone and BOP treatment for 20 weeks followed by testosterone pellets for life resulted in a 39% tumor incidence (three adenocarcinomas, one anaplastic carcinoma, and five squamous cell carcinomas). The overall results suggest that testosterone plays an important role in the initiation of prostatic carcinogenesis, whereas the promotional phase is governed by the interaction of testosterone with other factors.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 3664475</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Animals ; Applied sciences ; Biological and medical sciences ; Carcinogenesis, carcinogens and anticarcinogens ; Carcinogens ; Carcinoma - chemically induced ; Carcinoma - pathology ; Chemical agents ; DNA - biosynthesis ; Exact sciences and technology ; Male ; Medical sciences ; Nitrosamines - toxicity ; Orchiectomy ; Other techniques and industries ; Prostate - pathology ; Prostatic Neoplasms - chemically induced ; Prostatic Neoplasms - pathology ; Rats ; Rats, Inbred Strains ; Testosterone - pharmacology ; Tumors ; Urethral Neoplasms - chemically induced ; Urinary Bladder Neoplasms - chemically induced</subject><ispartof>Cancer research (Chicago, Ill.), 1987-11, Vol.47 (21), p.5699-5706</ispartof><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7484371$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7847871$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3664475$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>POUR, P. M</creatorcontrib><creatorcontrib>STEPAN, K</creatorcontrib><title>Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The effect of exogenous testosterone on prostatic carcinogenicity of N-nitrosobis(2-oxopropyl)amine (BOP) in intact and castrated rats was examined in Wistar-derived MRC rats. Daily administration of BOP (either s.c. or i.g.) for 3 days, at a dose of 20 mg/kg b.w. at the heights of prostatic cell proliferation induced by testosterone, led to development of a large number of prostatic tumors, the incidence of which, however, was dependent on the duration of testosterone administration. Testosterone given for life following BOP administration induced prostatic cancer in over 60% of rats, regardless of whether BOP was given orally or s.c., or whether the rats were orchiectomized or not, whereas tumor incidence was significantly lower in rats treated with testosterone for only a short period of time. One (3%) orchiectomized rat, which received testosterone only during BOP treatment, and four (15%) of rats treated with testosterone only for life also developed carcinomas. Histologically, a large number of BOP + testosterone-induced prostatic tumors were adenocarcinomas of various histological patterns and arose primarily from the dorsal lobe, whereas the great majority of squamous cell carcinomas were found in the ventral lobe. Simultaneously induced tumors were papillomas and carcinomas of the urinary bladder and urethra. Testosterone appeared to enhance the incidence of urinary bladder tumors, but not of the urethral tumors, whereas orchiectomy inhibited urethral carcinogenesis, and, to much lesser extent, urinary bladder tumor development. Rats treated weekly for 20 weeks with BOP (10 mg/kg/week i.g.) did not develop any prostatic tumors and all rats died of rectal cancer. Of rats treated similarly with BOP and with testosterone pellets for life following the last injection of BOP, 17% of rats developed prostatic cancer, all of the squamous cell type. Simultaneous testosterone and BOP treatment for 20 weeks followed by testosterone pellets for life resulted in a 39% tumor incidence (three adenocarcinomas, one anaplastic carcinoma, and five squamous cell carcinomas). The overall results suggest that testosterone plays an important role in the initiation of prostatic carcinogenesis, whereas the promotional phase is governed by the interaction of testosterone with other factors.</description><subject>Animals</subject><subject>Applied sciences</subject><subject>Biological and medical sciences</subject><subject>Carcinogenesis, carcinogens and anticarcinogens</subject><subject>Carcinogens</subject><subject>Carcinoma - chemically induced</subject><subject>Carcinoma - pathology</subject><subject>Chemical agents</subject><subject>DNA - biosynthesis</subject><subject>Exact sciences and technology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nitrosamines - toxicity</subject><subject>Orchiectomy</subject><subject>Other techniques and industries</subject><subject>Prostate - pathology</subject><subject>Prostatic Neoplasms - chemically induced</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Rats</subject><subject>Rats, Inbred Strains</subject><subject>Testosterone - pharmacology</subject><subject>Tumors</subject><subject>Urethral Neoplasms - chemically induced</subject><subject>Urinary Bladder Neoplasms - chemically induced</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><recordid>eNqFkM1KAzEUhYMotVYfQcjChS4GZjLJJLOU4k-h6EbX5eZnaGQmGZKU2hfz-cxocSuBGy7nu-dc7gmaV6wWBaeUnaJ5WZaiYJSTc3QR40duWVWyGZrVTUMpZ3P0tXJ6p5L1DvsOj8HHBMkqrCAo6_wAEYPTuPd7E_AuWAfhgFMAlbAzfuwhDhHLA1Z-kNYZnTUDaTAuTX7WpYmcHBTEPJYykWvEe5u2OJmYcqAJ3pkpe8xrZOSHfymcTXkdL228JYX_9BNw6O9gyDmX6KyDPpqr479A748Pb8vnYv36tFrer4staUUqGs2F0Z2pGt4YyVquWt0QpqUuawlEVLKTJL-a1ZUgrWxJp0rQpmEtJbxt6gW6_vUdd3IwejMGO-QLbI73y_rNUYeooO8COGXjH8YF5YJX_2JU0Dpj3_MHjKM</recordid><startdate>19871101</startdate><enddate>19871101</enddate><creator>POUR, P. M</creator><creator>STEPAN, K</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19871101</creationdate><title>Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine</title><author>POUR, P. M ; STEPAN, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h298t-6d78edfe1676eb597c9d625dbd03ba281bfb2b2b3531829b92fc0ade659427963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Animals</topic><topic>Applied sciences</topic><topic>Biological and medical sciences</topic><topic>Carcinogenesis, carcinogens and anticarcinogens</topic><topic>Carcinogens</topic><topic>Carcinoma - chemically induced</topic><topic>Carcinoma - pathology</topic><topic>Chemical agents</topic><topic>DNA - biosynthesis</topic><topic>Exact sciences and technology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nitrosamines - toxicity</topic><topic>Orchiectomy</topic><topic>Other techniques and industries</topic><topic>Prostate - pathology</topic><topic>Prostatic Neoplasms - chemically induced</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Rats</topic><topic>Rats, Inbred Strains</topic><topic>Testosterone - pharmacology</topic><topic>Tumors</topic><topic>Urethral Neoplasms - chemically induced</topic><topic>Urinary Bladder Neoplasms - chemically induced</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>POUR, P. M</creatorcontrib><creatorcontrib>STEPAN, K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>POUR, P. M</au><au>STEPAN, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1987-11-01</date><risdate>1987</risdate><volume>47</volume><issue>21</issue><spage>5699</spage><epage>5706</epage><pages>5699-5706</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>The effect of exogenous testosterone on prostatic carcinogenicity of N-nitrosobis(2-oxopropyl)amine (BOP) in intact and castrated rats was examined in Wistar-derived MRC rats. Daily administration of BOP (either s.c. or i.g.) for 3 days, at a dose of 20 mg/kg b.w. at the heights of prostatic cell proliferation induced by testosterone, led to development of a large number of prostatic tumors, the incidence of which, however, was dependent on the duration of testosterone administration. Testosterone given for life following BOP administration induced prostatic cancer in over 60% of rats, regardless of whether BOP was given orally or s.c., or whether the rats were orchiectomized or not, whereas tumor incidence was significantly lower in rats treated with testosterone for only a short period of time. One (3%) orchiectomized rat, which received testosterone only during BOP treatment, and four (15%) of rats treated with testosterone only for life also developed carcinomas. Histologically, a large number of BOP + testosterone-induced prostatic tumors were adenocarcinomas of various histological patterns and arose primarily from the dorsal lobe, whereas the great majority of squamous cell carcinomas were found in the ventral lobe. Simultaneously induced tumors were papillomas and carcinomas of the urinary bladder and urethra. Testosterone appeared to enhance the incidence of urinary bladder tumors, but not of the urethral tumors, whereas orchiectomy inhibited urethral carcinogenesis, and, to much lesser extent, urinary bladder tumor development. Rats treated weekly for 20 weeks with BOP (10 mg/kg/week i.g.) did not develop any prostatic tumors and all rats died of rectal cancer. Of rats treated similarly with BOP and with testosterone pellets for life following the last injection of BOP, 17% of rats developed prostatic cancer, all of the squamous cell type. Simultaneous testosterone and BOP treatment for 20 weeks followed by testosterone pellets for life resulted in a 39% tumor incidence (three adenocarcinomas, one anaplastic carcinoma, and five squamous cell carcinomas). The overall results suggest that testosterone plays an important role in the initiation of prostatic carcinogenesis, whereas the promotional phase is governed by the interaction of testosterone with other factors.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>3664475</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1987-11, Vol.47 (21), p.5699-5706
issn 0008-5472
1538-7445
language eng
recordid cdi_pubmed_primary_3664475
source EZB-FREE-00999 freely available EZB journals
subjects Animals
Applied sciences
Biological and medical sciences
Carcinogenesis, carcinogens and anticarcinogens
Carcinogens
Carcinoma - chemically induced
Carcinoma - pathology
Chemical agents
DNA - biosynthesis
Exact sciences and technology
Male
Medical sciences
Nitrosamines - toxicity
Orchiectomy
Other techniques and industries
Prostate - pathology
Prostatic Neoplasms - chemically induced
Prostatic Neoplasms - pathology
Rats
Rats, Inbred Strains
Testosterone - pharmacology
Tumors
Urethral Neoplasms - chemically induced
Urinary Bladder Neoplasms - chemically induced
title Induction of prostatic carcinomas and lower urinary tract neoplasms by combined treatment of intact and castrated rats with testosterone propionate and N-nitrosobis(2-oxopropyl)amine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A44%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Induction%20of%20prostatic%20carcinomas%20and%20lower%20urinary%20tract%20neoplasms%20by%20combined%20treatment%20of%20intact%20and%20castrated%20rats%20with%20testosterone%20propionate%20and%20N-nitrosobis(2-oxopropyl)amine&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=POUR,%20P.%20M&rft.date=1987-11-01&rft.volume=47&rft.issue=21&rft.spage=5699&rft.epage=5706&rft.pages=5699-5706&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E3664475%3C/pubmed_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h298t-6d78edfe1676eb597c9d625dbd03ba281bfb2b2b3531829b92fc0ade659427963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/3664475&rfr_iscdi=true